Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Texas: Anderson Cancer Center
- University of Texas M.D. Anderson Cancer Center, Houston
- University of Texas M. D. Anderson Cancer Center, Houston

Texas: Anderson Cancer Center Newsletter

<![CDATA[Contemporary RCC trial adds fresh lenvatinib/everolimus PFS perspective]]> 18 Oct 2025 15:01 GMT
… , Division of Cancer Medicine, MD Anderson Cancer Center, said during a presentation of …
<![CDATA[Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study]]> 18 Oct 2025 17:13 GMT
… , The University of Texas MD Anderson Cancer Center, said during a presentation of …
‘Cancer Won, Guys’: 21-Year-Old Battling Cancer Shares Heart-Wrenching Post On Seeing Diwali For The ‘Last Time’ 18 Oct 2025 11:50 GMT
… the University of Texas MD Anderson Cancer Center said in a publication that …
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients 18 Oct 2025 10:58 GMT
… The University of Texas MD Anderson Cancer Center showed that a targeted therapy …
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients 18 Oct 2025 10:58 GMT
… The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and …
ESMO 2025: Belzutifan Demonstrates Tumor Reduction and Symptom Relief in Patients with Rare Neuroendocrine Tumors 18 Oct 2025 09:31 GMT
… the University of Texas MD Anderson Cancer Center marks a pivotal moment, demonstrating … References: University of Texas MD Anderson Cancer Center Camilo Jimenez, M.D. profile …
ESMO 2025: Dual Targeted Therapy Demonstrates Potential in Treating Advanced Kidney Cancer After Prior Therapies 18 Oct 2025 07:50 GMT
… The University of Texas MD Anderson Cancer Center has unveiled promising advancements in … ;106 – University of Texas MD Anderson Cancer Center: https://www.mdanderson …
ESMO 2025: Oral Drug Demonstrates Promising Anti-Tumor Activity in Patients with Advanced Lung Cancer 18 Oct 2025 02:57 GMT
… The University of Texas MD Anderson Cancer Center. The Phase I/II …
<![CDATA[Osimertinib Plus Local Consolidative Therapy Significantly Extends PFS in EGFR-Mutant NSCLC]]> 18 Oct 2025 01:17 GMT
… The University of Texas MD Anderson Cancer Center, in Houston. What Unmet Need …
<![CDATA[Sevabertinib Effective in Pretreated and First-Line HER2-Mutant NSCLC]]> 17 Oct 2025 22:21 GMT
… the University of Texas MD Anderson Cancer Center, and coauthors, in the presentation …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS